Caprock Group, Inc. Elanco Animal Health Inc Transaction History
Caprock Group, Inc.
- $2.43 Billion
- Q2 2024
A detailed history of Caprock Group, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Caprock Group, Inc. holds 62,931 shares of ELAN stock, worth $908,723. This represents 0.04% of its overall portfolio holdings.
Number of Shares
62,931
Previous 62,936
0.01%
Holding current value
$908,723
Previous $1.02 Million
11.33%
% of portfolio
0.04%
Previous 0.06%
Shares
7 transactions
Others Institutions Holding ELAN
# of Institutions
447Shares Held
478MCall Options Held
3.1MPut Options Held
1.26M-
Dodge & Cox San Francisco, CA83.6MShares$1.21 Billion0.76% of portfolio
-
Primecap Management CO Pasadena, CA52.8MShares$762 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.4MShares$714 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD28.1MShares$405 Million0.05% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$336 Million0.01% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.85B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...